Novel Treatments Spur Acne Care.
NEW YORK -- Suppliers of acne treatments are innovating to deliver new products that are easier on the skin.
Clixit LLC says that its acne treatments are made without benzoyl peroxide, a staple of acne-fighting products for nearly a century. Benzoyl peroxide is a peeling agent that works on acne blemishes but can damage skin cells, Clixit says. That's why its acne treatments are formulated with a powerful blend of ingredients designed to treat the underlying cause of acne, control oil, reduce irritation and swelling, and safely condition the skin.
"It has been years since something innovative and new was introduced to the over-the-counter acne market," Clixit says. "In a category that has seen steady decline in the past 18 months and is down about 17% in most markets, Clixit offers retailers and consumers alike something new and exciting."
The Orlando, Fla.-based company says it is pleased with early results from its two acne treatment products--Acne Eraser and Heal & Conceal click pens--that were introduced a year ago. The eraser uses a proprietary acne healing formula that reduces the size and severity of pimples in less than 24 hours, according to Clixit.
Neutrogena, the market leader in O-T-C acne treatments, has incorporated a phototherapy technique used by dermatologists into a new Light Therapy mask that uses red and blue beams from light-emitting diodes (LEDs) to reduce inflammation and clear pimples. Neutrogena's beam-emitting acne masks are available for under $35 from such retailers as Walmart and Target Corp.
Galderma Laboratories L.P. announced in July that the Food and Drug Administration had approved its Differin Gel for acne. "This approval makes Differin Gel the first and only O-T-C acne product containing a full prescription-strength retinoid," the company says. "It also marks the first new, FDA-approved active ingredient to be introduced to the O-T-C acne category in over three decades."
The Fort Worth-based company says it expects Differin Gel will be a game changer in the acne category.
Galderma recently made two additions to its Benzac Acne Solutions product line--Benzac Skin Refining Mask and Benzac Acne Eliminating Cleanser --that the company says allow teens to customize a highly effective skin care regimen that quickly clears up mild-to-moderate acne and helps keep it from coming back.
Acne treatments generated $142.3 million in revenue at the nation's mass market retailers in the 12 weeks to September 4, according to IRI data. Neutrogena's acne treatments accounted for a little over one-third of that total ($47.7 million), IRI says. Johnson & Johnson's acne treatment had the second-largest market share, with sales of $23.4 million. Reckitt Benckiser, owner of the Clearasil brand, notched sales of $16.7 million, while private label acne treatments accounted for $15.8 million in sales through mass channels.
Overall, the category was down about 6.4% compared to the year-earlier period. Clearasil-branded treatments sustained some of the biggest declines. Sales of private label acne treatments declined nearly 3% from the comparable period a year earlier.